Display options
Cite
Bianic F, Campbell R, De SP, et al. Cost-Effectiveness Of Everolimus Plus Reduced Tacrolimus In De Novo Liver-Recipients In The Italian Setting. Value Health. 2014;17(7):A367doi: 10.1016/j.jval.2014.08.824.
Bianic, F., Campbell, R., De, S. P., Roccia, A., & Gregson, G. (2014). Cost-Effectiveness Of Everolimus Plus Reduced Tacrolimus In De Novo Liver-Recipients In The Italian Setting. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A367. https://doi.org/10.1016/j.jval.2014.08.824
Bianic, F, et al. "Cost-Effectiveness Of Everolimus Plus Reduced Tacrolimus In De Novo Liver-Recipients In The Italian Setting." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A367. doi: https://doi.org/10.1016/j.jval.2014.08.824
Bianic F, Campbell R, De SP, Roccia A, Gregson G. Cost-Effectiveness Of Everolimus Plus Reduced Tacrolimus In De Novo Liver-Recipients In The Italian Setting. Value Health. 2014 Nov;17(7):A367. doi: 10.1016/j.jval.2014.08.824. Epub 2014 Oct 26. PMID: 27200771.
Copy Download .nbib Format: NLM
Share it on

Value Health. 2014 Nov;17(7):A367. doi: 10.1016/j.jval.2014.08.824. Epub 2014 Oct 26.

Cost-Effectiveness Of Everolimus Plus Reduced Tacrolimus In De Novo Liver-Recipients In The Italian Setting.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

F Bianic, R Campbell, Simone P De, A Roccia, G Gregson

Affiliations

  1. OptumInsight, Paris, France.
  2. OptumInsight, Uxbridge, UK.
  3. University of Pisa Medical School Hospital, Pisa, Italy.
  4. Novartis Farma, Origgio, Italy.
  5. Novartis Pharma AG, Basel, Switzerland.

PMID: 27200771 DOI: 10.1016/j.jval.2014.08.824

[No abstract available.]

Publication Types